TYRA - NASDAQ

Tyra Biosciences, Inc.

TYRA·NASDAQ

$28.69

-5.6%

HealthcareBiotechnology

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.71B

EPS-2.0100

P/E Ratio-14.27

Earnings Date08/06/2026

tyra

Total Non-Current Assets

Last Annual Value

17.16M

3-Year CAGR

24%

5-Year CAGR

88%

10-Year CAGR

46%

Adjust for Inflation

Tyra Biosciences, Inc. Competitors Analysis of Total Non-Current Assets

TYRA · NASDAQ

Company	Total Non-Current Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
Tyra Biosciences, Inc. NASDAQ:TYRA	17.16M	6.5%	45.4%	N/A
Savara Inc. NASDAQ:SVRA	11.82M	0.6%	0.4%	-1.9%
ProKidney Corp. NASDAQ:PROK	54.90M	5.8%	33.3%	N/A
Kura Oncology, Inc. NASDAQ:KURA	29.70M	21.8%	20.4%	40.2%
Prime Medicine, Inc. NASDAQ:PRME	161.44M	46.9%	38.9%	N/A
Rezolute, Inc. NASDAQ:RZLT	4.34M	-38.6%	47.8%	-3.8%
Maravai LifeSciences Holdings, Inc. NASDAQ:MRVI	474.33M	-15.5%	-16.6%	N/A
EyePoint Pharmaceuticals, Inc. NASDAQ:EYPT	35.34M	50.4%	6.6%	35.8%
Geron Corporation NASDAQ:GERN	50.27M	-1.6%	5.3%	13.5%
Day One Biopharmaceuticals, Inc. NASDAQ:DAWN	22.73M	208.5%	118.8%	N/A

Tyra Biosciences, Inc. Fair Value Envelope

TYRA · NASDAQ

Our analysis suggests that TYRA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $28.69, this represents a potential HIDDEN relative to our calculated worth for Tyra Biosciences, Inc..

HIDDEN

Intrinsic Value

Current Price: $28.69

Related Guides

Blog Categories

Continue your TYRA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.